Invesaro

Stocks Health care SCLX

NASDAQ · Health care

Scilex Holding Co (SCLX)

Scilex Holding Co brought in $31.6M of revenue over the twelve months to June 30, 2026, down 28.5% from a year earlier. It posted a net loss of $464.6M. Operating cash flow minus capital spending left $3.7M of free cash flow in fiscal 2025. At June 30, 2026 it held $566K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Free, no password. An email when SCLX files with the SEC.

Price
$1.74
+2.35% on the day · November 9, 2026
52-week range $1.61 to $16.81
Market cap
$14.8M
Revenue (last 12 months)
$31.6M
-28.5% year on year
Net margin
-1,469.8%

Key facts about Scilex Holding Co

Net worth
Scilex Holding Co has a market value (market cap) of $14.8M at the latest share price, and shareholders' equity of -$308.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $30.3M (-46.5% year on year), with a net loss of $374.1M. Over the 12 months to June 30, 2026: revenue $31.6M, net loss $464.6M.
Cash flow
In fiscal 2025 operations brought in $3.8M of cash; after $133K of capital spending, free cash flow was $3.7M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Scilex Holding Co's next report was expected around November 9, 2026 and is not on file with the SEC yet.

What Scilex Holding Co does

Scilex Holding Co is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker SCLX.

Revenue and profit by year

Revenue
FY20: $23.6M $23.6M FY20FY21: $31.3M $31.3M FY21FY22: $38M $38M FY22FY23: $46.7M $46.7M FY23FY24: $56.6M $56.6M FY24FY25: $30.3M $30.3M FY25
Net income
FY20: -$47.5M -$47.5M FY20FY21: -$88.4M -$88.4M FY21FY22: -$23.4M -$23.4M FY22FY23: -$114.3M -$114.3M FY23FY24: -$72.8M -$72.8M FY24FY25: -$374.1M -$374.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$30.3M-$346M-$374.1M-$36.48$3.7M
2024$56.6M-$83.4M-$72.8M-$8.05$19.3M
2023$46.7M-$105.4M-$114.3M-$16.89-$20.7M
2022$38M-$50.6M-$23.4M-$2.24-$21.3M
2021$31.3M-$35.8M-$88.4M-$8.84-$28.7M
2020$23.6M-$35.3M-$47.5M-$4.75-$31.5M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

A report was expected around November 9, 2026 and is not on file yet.

Estimated from its filing rhythm: about 86 days after its last report of August 14, 2026, its usual gap. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where SCLX ranks in Health care

Revenue$30.3M
#451 of 751 in Health care · Bottom 40%
Revenue growth-46.5%
#520 of 532 in Health care · Bottom 2%
Net margin-1,236.4%
#539 of 544 in Health care · Bottom 1%
Free cash flow margin12.2%
#113 of 490 in Health care · Top 23%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

It paid out $8.7M in cash dividends.

Fiscal yearPer sharePaid outOf profit
2024n/a$8.7Mn/a
2023n/a$8.7Mn/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Scilex Holding Co has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 29, 2026
    Material agreement8-KScilex Holding Company increased its uncommitted revolving credit line to Vivasor from $20,000,000 to $30,000,000.
  2. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 23% to $7.6M versus the same quarter last year; diluted EPS -$16.65 versus -$7.42.
  3. August 12, 2026
  4. July 22, 2026
  5. July 7, 2026
  6. July 6, 2026
  7. June 30, 2026
  8. June 29, 2026
  9. June 26, 2026
  10. June 24, 2026

Recent insider filings (Forms 3, 4 and 144): 9, the latest on July 7, 2026. Insider transactions on SEC

What is SCLX worth? A DCF from its reported cash flow

Insider trades

What the people running Scilex Holding Co did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
July 3, 2026 SCLX Stock Acquisition JV LLC10% owner Other change 500,000 - - Form 4
December 30, 2025 Scilex Holding Co10% owner Sold 9,657,300 $0.54 $5.2M Form 4
December 29, 2025 Scilex Holding Co10% owner Sold 7,310,984 $0.66 $4.8M Form 4
December 26, 2025 Scilex Holding Co10% owner Sold 3,689,016 $0.75 $2.8M Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SCLX

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Scilex Holding Company13D, may seek influence with 1 related filers 78.85% 181,520,112 June 26, 2026
SCLX Stock Acquisition JV LLC13D, may seek influence 11.4% 30,029,378 July 7, 2026

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 73 managers reported a position.

HolderSharesValueChange on quarter
Vanguard Capital Management LLC301,292$2.4M+37,242
BlackRock, Inc.109,417$853.5K+6,621
Vanguard Fiduciary Trust Co45,822$357.4K+6,164
Jacobs Levy Equity Management, Inc41,163$321.1Knew
State Street Corp35,376$275.9K0
UBS Group AG33,376$260.3K+26,908
Renaissance Technologies LLC33,064$257.9K-3,800
Citadel Advisors LLC27,497$214.5Knew
Ashton Thomas Private Wealth, LLC18,482$144.2K+493
Northern Trust Corp15,047$117.4K+14
Morgan Stanley4,032$31.5K-7,941
Vanguard Global Advisers, LLC2,937$22.9K0
Osaic Holdings, Inc.2,339$18.2K+2,241
Creative Financial Designs Inc1,853$14.5K0
Royal Bank of Canada1,745$14K+149
Jones Financial Companies Lllp1,755$12.5K+1,003
Larson Financial Group LLC1,419$11.1K+1,377
MetLife Investment Management, LLC1,090$8.5K0
Deutsche Bank AG\800$6.2K0
Versant Capital Management, Inc761$5.9K0

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 245,403,523 shares in total, about $427M at the last price.

HolderSharesAs of
Scilex Holding Co10% owner 244,445,260 December 30, 2025
SCLX Stock Acquisition JV LLC10% owner 958,263 July 3, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SCLX

What does Scilex Holding Co do?

Scilex Holding Co is a company in the Health care sector, listed on NASDAQ as SCLX. Its shares trade on NASDAQ under the ticker SCLX.

What is Scilex Holding Co's net worth?

Scilex Holding Co has a market value (market cap) of $14.8M at the latest share price, and shareholders' equity of -$308.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Scilex Holding Co profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $464.6M on revenue of $31.6M.

How much revenue does Scilex Holding Co make?

Over the twelve months to June 30, 2026 Scilex Holding Co reported revenue of $31.6M. That is 28.5% less than a year earlier.

When did Scilex Holding Co last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 29, 2026.

When is Scilex Holding Co's next earnings report?

Scilex Holding Co's next report was expected around November 9, 2026 and is not on file with the SEC yet.

Similar companies

Compare SCLX with

Compare SCLX with any company

Follow SCLX

Get an email when Scilex Holding Co files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when SCLX files with the SEC.

Where the numbers come from

Financial figures are the values Scilex Holding Co tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.